Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

Senn, H J; Maibach, R; Castiglione, M; Jungi, W F; Cavalli, F; Leyvraz, S; Obrecht, J P; Schildknecht, O; Siegenthaler, P.

J Clin Oncol ; 15(7): 2502-9, 1997 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-9215818

2.

Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.

Jungi, W F; Senn, H J.

J Natl Cancer Inst Monogr ; (11): 71-6, 1992.

Artículo en Inglés | MEDLINE | ID: mdl-1627433

3.

Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.

Senn, H J; Amgwerd, R; Jungi, W F; Hochuli, R; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G; Simon, B; Lanz, R; Bigler, R; Seiler, S.

Recent Results Cancer Res ; 80: 177-84, 1982.

Artículo en Inglés | MEDLINE | ID: mdl-7036281

4.

[Adjuvant chemotherapy in breast cancer: status in 1984]. / Adjuvante Chemotherapie beim Mammakarzinom: stand 1984.

Jungi, W F.

Wien Klin Wochenschr ; 96(13): 486-92, 1984 Jun 22.

Artículo en Alemán | MEDLINE | ID: mdl-6382805

5.

[The significance of selenium supply]. / Zur Bedeutung der Selenversorgung.

Jungi, W F.

Soz Praventivmed ; 34(2): 71-4, 1989.

Artículo en Alemán | MEDLINE | ID: mdl-2665380

6.

Diet to prevent gastrointestinal cancer?

Jungi, W F.

Recent Results Cancer Res ; 121: 286-92, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1857865

7.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.

Senn, H J; Jungi, W F; Amgwerd, R; Hochuli, E; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G.

Recent Results Cancer Res ; 96: 90-101, 1984.

Artículo en Inglés | MEDLINE | ID: mdl-6528092

8.

[Alternative treatment methods in cancer]. / Alternative Behandlungsmethoden bei Krebskrankheiten.

Jungi, W F; Senn, H J.

Med Monatsschr Pharm ; 19(1): 6-16, 1996 Jan.

Artículo en Alemán | MEDLINE | ID: mdl-8583981

9.

[Natural substances in gynecologic oncology]. / Naturstoffe in der gynäkologischen Onkologie.

Jungi, W F.

Gynakologe ; 27(6): 381-6, 1994 Dec.

Artículo en Alemán | MEDLINE | ID: mdl-7843619

10.

[Complementary medicine for chronic and terminal illness]. / Stellenwert der Komplementärmedizin bei der Betreuung Schwerkranker.

Jungi, W F.

Praxis (Bern 1994) ; 93(7): 219-24, 2004 Feb 11.

Artículo en Alemán | MEDLINE | ID: mdl-15008276

11.

[Risks of alternative cancer treatment]. / Risiken alternativer Krebsbehandlung.

Jungi, W F.

Onkologie ; 9(4): 231-4, 1986 Aug.

Artículo en Alemán | MEDLINE | ID: mdl-3531950

12.

[Complementary medicine--health policy and health care costs]. / Komplementärmedizin--Gesundheitspolitik und Gesundheitskosten.

Jungi, W F.

Praxis (Bern 1994) ; 86(41): 1593-7, 1997 Oct 08.

Artículo en Alemán | MEDLINE | ID: mdl-9417579

13.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.

Senn, H J; Barett-Mahler, A R; Jungi, W F.

Eur J Cancer Clin Oncol ; 25(3): 513-25, 1989 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-2703006

14.

[Why do cancer patients use alternative medicine?]. / Warum benützen Tumorpatienten Alternativmedizin?

Morant, R; Jungi, W F; Koehli, C; Senn, H J.

Schweiz Med Wochenschr ; 121(27-28): 1029-34, 1991 Jul 09.

Artículo en Alemán | MEDLINE | ID: mdl-1882214

15.

Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.

Senn, H J; Jungi, W F; Amgwerd, R; Hochuli, E; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G.

NCI Monogr ; (1): 129-34, 1986.

Artículo en Inglés | MEDLINE | ID: mdl-3534585

16.

Dangerous nutrition.

Jungi, W F.

Support Care Cancer ; 11(4): 197-8, 2003 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-12673456

17.

Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.

Jungi, W F; Senn, H J; Amgwerd, R; Hochuli, E.

Eur J Cancer (1965) ; Suppl 1: 169-72, 1980.

Artículo en Inglés | MEDLINE | ID: mdl-7032928

18.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.

Senn, H J; Jungi, W F; Amgwerd, R; Sprenger, F; Hochueli, R; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G; Simeon, B; Lanz, R; Bigler, R.

Antibiot Chemother (1971) ; 24: 213-28, 1978.

Artículo en Inglés | MEDLINE | ID: mdl-350137

19.

Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.

Senn, H J; Jungi, W F; Amgwerd, R; Sprenger, F; Hochuli, E; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Simeon, B; Lanz, R; Bigler, R.

Haematol Blood Transfus ; 22: 47-60, 1978.

Artículo en Inglés | MEDLINE | ID: mdl-374199

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.

Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.

[Adjuvant chemotherapy in breast cancer: status in 1984]. / Adjuvante Chemotherapie beim Mammakarzinom: stand 1984.

[The significance of selenium supply]. / Zur Bedeutung der Selenversorgung.

Diet to prevent gastrointestinal cancer?

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.

[Alternative treatment methods in cancer]. / Alternative Behandlungsmethoden bei Krebskrankheiten.

[Natural substances in gynecologic oncology]. / Naturstoffe in der gynäkologischen Onkologie.

[Complementary medicine for chronic and terminal illness]. / Stellenwert der Komplementärmedizin bei der Betreuung Schwerkranker.

[Risks of alternative cancer treatment]. / Risiken alternativer Krebsbehandlung.

[Complementary medicine--health policy and health care costs]. / Komplementärmedizin--Gesundheitspolitik und Gesundheitskosten.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.

[Why do cancer patients use alternative medicine?]. / Warum benützen Tumorpatienten Alternativmedizin?

Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.

Dangerous nutrition.

Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.

Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.